An Arkansas State University student will spend his summer at Harvard University. Jonathan Toma received a Public Policy and International Affairs (PPIA) Junior Summer Institute Fellowship. He is a ...

Eli Lilly and Company (NYSE: LLY) announced on February 23, 2026, that the U.S. Food and Drug Administration has approved a ...

Eli Lilly on Monday launched a new form of its blockbuster obesity drug, Zepbound, that offers a month's worth of doses in a ...

Eli Lilly (LLY) stock falls as rival Novo Nordisk (NVO) plans to cut Wegovy, Ozempic & Rybelsus U.S. list prices from Jan 1, ...

Novo unveiled late-stage trial data for its CagriSema drug on Monday that not only showed it underperforming Lilly's rival Zepbound, but appeared to show weight loss with Zepbound was ‌better than ...

Eli Lilly's financial results should remain strong through economic and market downturns. The company's deep pipeline should help power growth beyond the current GLP-1 cycle. Eli Lilly has ...

The drugmaker unveiled a new Zepbound delivery system as its main rival absorbed fresh clinical and stock-market blows.

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo ...

In the lucrative obesity drug race, there is Eli Lilly — and then there's everybody else. A pair of headlines Monday ...

Eli Lilly announced on " Good Morning America " Monday that its GLP-1 weight-loss drug Zepbound will now be available in a ...

President Donald Trump says he wants a global tariff of 15%, up from 10% he’d announced earlier after the U.S. Supreme Court ...

Sidharth Malhotra’s father and former Merchant Navy captain, passed away after a prolonged illness. The actor remembered him ...